USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ARTIFICIAL CELL TECHNOLOGIES, INC.
City: NEW HAVEN
State: CT
Zip+4: 06511
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,531,582.00 3

Award List:

Polypeptide Multilayer Nanofilms for Synthetic Biomatrix Development

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $331,582.00
Abstract:
DESCRIPTION (provided by applicant): This SBIR Phase I project will determine the feasibility of applying polypeptide multilayer nanofilm technology to synthetic biomatrix development and commercialization. These nanofilms are a type of surface coating for cell and tissue culture. Immediate in vitro… More

Synthetic nanocapsule malaria vaccines

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas J. Powell
Award Amount: $600,000.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to produce novel synthetic malaria vaccines based on epitopes of the circumsporozoite (CS) protein of Plasmodium falciparum, the causative agent of human malaria. Malaria is one of the major diseases in the developing world, causing… More

Synthetic nanoparticle vaccines for RSV

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Thomas J. Powell – 203-772-3430
Award Amount: $600,000.00
Abstract:
DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the most important cause of severe lower respiratory tract illness in infants and the elderly. There is no approved vaccine despite decades of effort. Early attempts to develop a formalin- inactivated vaccine (FI-RSV) resulted… More